Template:Central line contraindications: Difference between revisions

(Created page with "==Contraindications== *Infection over the placement site *Distortion of landmarks by trauma or congenital anomalies (including c-collar) *Pathologic conditions, including SVC...")
 
(divided into absolute and relative, added site-specific contraindications)
Line 1: Line 1:
==Contraindications==
==Contraindications==
===Absolute===
*Infection over the placement site
*Infection over the placement site
*Distortion of landmarks by trauma or congenital anomalies (including c-collar)
*Anatomic obstruction (thrombosis of target vein, other anatomic variance)
*Pathologic conditions, including SVC syndrome
*Site-specific
*Current venous thrombosis in target vessel
**Subclavian - trauma/fracture to ipsilateral clavicle or proximal ribs
 
===Relative===
*Coagulopathy (see below)
*Distortion of landmarks by trauma or congenital anomalies
*Prior vessel injury or procedures
*Prior vessel injury or procedures
*Morbid obesity
*Morbid obesity
*Uncooperative patient
*Uncooperative/combative patient


{{Central line with coagulopathy}}
{{Central line with coagulopathy}}

Revision as of 21:30, 19 June 2015

Contraindications

Absolute

  • Infection over the placement site
  • Anatomic obstruction (thrombosis of target vein, other anatomic variance)
  • Site-specific
    • Subclavian - trauma/fracture to ipsilateral clavicle or proximal ribs

Relative

  • Coagulopathy (see below)
  • Distortion of landmarks by trauma or congenital anomalies
  • Prior vessel injury or procedures
  • Morbid obesity
  • Uncooperative/combative patient

Central line if coagulopathic

  • Preferentially use a compressible site such as the femoral location (avoid the IJ and subclavian if possible, though IJ preferred over subclavian)
  • No benefit to giving FFP unless artery is punctured[1]
  1. Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy—a prospective audit. Intens Care Med 1999; 25:5
  2. Morado M.et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 2001; 7:551–556